Free Trial

Aflac Incorporated (NYSE:AFL) Shares Sold by Fidelis Capital Partners LLC

Aflac logo with Finance background

Fidelis Capital Partners LLC reduced its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 39.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,232 shares of the financial services provider's stock after selling 5,909 shares during the quarter. Fidelis Capital Partners LLC's holdings in Aflac were worth $996,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Norges Bank acquired a new stake in shares of Aflac in the 4th quarter valued at about $349,699,000. GAMMA Investing LLC boosted its position in shares of Aflac by 12,313.9% in the 1st quarter. GAMMA Investing LLC now owns 1,504,067 shares of the financial services provider's stock valued at $167,237,000 after purchasing an additional 1,491,951 shares during the period. Northern Trust Corp boosted its position in shares of Aflac by 22.9% in the 4th quarter. Northern Trust Corp now owns 7,296,014 shares of the financial services provider's stock valued at $754,700,000 after purchasing an additional 1,357,753 shares during the period. Vanguard Group Inc. boosted its position in shares of Aflac by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider's stock valued at $5,310,640,000 after purchasing an additional 653,275 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Aflac by 11.9% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,250,905 shares of the financial services provider's stock valued at $543,154,000 after purchasing an additional 556,394 shares during the period. 67.44% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Aflac

In other news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $106.79, for a total transaction of $106,790.00. Following the completion of the transaction, the director directly owned 26,096 shares of the company's stock, valued at approximately $2,786,791.84. This represents a 3.69% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total value of $3,906,830.00. Following the transaction, the director directly owned 70,992 shares of the company's stock, valued at approximately $7,496,045.28. This trade represents a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 40,750 shares of company stock valued at $4,304,295. Corporate insiders own 0.90% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on AFL. Wells Fargo & Company upped their target price on Aflac from $103.00 to $105.00 and gave the company an "equal weight" rating in a research report on Thursday. JPMorgan Chase & Co. upped their target price on Aflac from $96.00 to $100.00 and gave the company a "neutral" rating in a research report on Tuesday. Wall Street Zen cut Aflac from a "hold" rating to a "sell" rating in a research report on Monday, May 5th. Morgan Stanley upped their price objective on Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a research note on Monday, May 19th. Finally, Piper Sandler upped their price objective on Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $107.07.

Check Out Our Latest Analysis on AFL

Aflac Stock Performance

Shares of AFL stock opened at $101.56 on Friday. The company has a market cap of $54.91 billion, a price-to-earnings ratio of 15.87, a price-to-earnings-growth ratio of 3.17 and a beta of 0.81. The stock has a 50 day simple moving average of $103.79 and a 200-day simple moving average of $105.23. Aflac Incorporated has a 12-month low of $91.99 and a 12-month high of $115.50. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL - Get Free Report) last issued its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The business had revenue of $3.40 billion for the quarter, compared to analysts' expectations of $4.53 billion. Aflac had a return on equity of 15.55% and a net margin of 21.27%. The business's quarterly revenue was down 37.5% on a year-over-year basis. During the same period last year, the company posted $1.66 earnings per share. On average, equities analysts forecast that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were paid a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac's dividend payout ratio (DPR) is 36.25%.

About Aflac

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Further Reading

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Aflac Right Now?

Before you consider Aflac, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.

While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines